Comprehensive analysis on Biosimulation Market | key Players are: Dassault Systemes SE, Acceryls, Schrodinger, Leadscope, Certara, L.P, Entelos, Advanced Chemistry Development, Evidera, Simulations Plus

The global biosimulation market is slated to touch a value of about US$ 1,750 Mn in the year 2022 and grow at a robust CAGR during the assessment period.

The report has also included the profiles of some of the leading companies in the biosimulation market like Dassault Systemes SE, Acceryls Inc., Schrodinger, Inc., Leadscope Inc., Certara, L.P., Entelos, Inc., Advanced Chemistry Development, Inc., Evidera, Inc., Simulations Plus, Inc. and Genedata AG.

Request Sample of This Report @ https://www.persistencemarketresearch.com/samples/3726

In the process of biosimulation, the computer aided mathematical models are used to simulate the biological processes. Biosimulation is an important part of systems biology and helps in the discov-ery and development of new drugs, in the area of drug metabolism and in the modeling of biomedi-cal systems that are complex. There is a growing demand for reduction in the cost of discovery of new drugs and the risk of failure at a later stage in the development of new drugs is too high. In or-der to counter such problems, biosimulation is used as a predictive tool and it helps in the prediction of the future outcomes of the drug development by simulation of the biological processes involved. This is the main factor supporting the growth of the global biosimulation market. However, high costs associated with the R&D related to biosimulation and a lack of qualified workforce are the main restraints hampering the growth of this market.

As per the forecast of Persistence Market Research, the drug development segment is slated to reach a value of nearly US$ 1,000 Mn in 2022. The drug development segment is expected to gain market share by the end of the year 2022. The largest share is contributed by the North America region in the drug development segment.

Persistence Market Research forecasts the U.S. biosimulation market to exhibit a compound annual growth rate (CAGR) of more than 13% from 2017 to 2022.

Request For Methodology @ https://www.persistencemarketresearch.com/methodology/3726

As per the forecast of Persistence Market Research, the services product type segment is slated to touch a value of nearly US$ 700 Mn in the year 2022. This represents a robust CAGR growth during the assessment period of 2017-2022. The services product type segment is estimated to account for more than one-third of the revenue share of the product segment by the year 2017 and is forecasted to gain market share by 2022 over 2017.

As per the forecast of Persistence Market Research, the pharmaceutical and biotech companies segment will reach a value of about US$ 350 Mn in the year 2017. This represents a robust CAGR growth during the forecast period. The pharmaceutical and biotech companies segment is forecasted to account for more than one-third of the total revenue share of the end user segment by the end of the year 2017 and is expected to lose in market share by 2022 as compared with the year 2017.

Table of Content

1. Global Biosimulation Market - Executive Summary

2. Global Biosimulation Market Overview
2.1. Introduction
2.1.1. Global Biosimulation Market Taxonomy

2.1.2. Global Biosimulation Market Definition
2.2. Global Biosimulation Market Size (US$ Mn) and Forecast, 2012-2022
2.2.1. Global Biosimulation Market Y-o-Y Growth

2.3. Global Biosimulation Market Dynamics
2.4. Supply Chain
2.5. Cost Structure
2.6. Key Participants Market Presence (Intensity Map) By Region

3. Global Biosimulation Market Analysis and Forecast By Product
3.1. Global Biosimulation Market Size and Forecast By Product, 2012-2022
3.1.1. Software Market Size and Forecast, 2012-2022
3.1.1.1. Revenue (US$ Mn) Comparison, By Region

3.1.1.2. Market Share Comparison, By Region
3.1.1.3. Y-o-Y growth Comparison, By Region
3.1.2. Services Market Size and Forecast, 2012-2022

3.1.2.1. Revenue (US$ Mn) Comparison, By Region
3.1.2.2. Market Share Comparison, By Region
3.1.2.3. Y-o-Y growth Comparison, By Region

4. Global Biosimulation Market Analysis and Forecast By End User
4.1. Global Biosimulation Market Size and Forecast By End User, 2012-2022
4.1.1. Academic and Government Research Institutes Market Size and Forecast, 2012-2022
4.1.1.1. Revenue (US$ Mn) Comparison, By Region

4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. Pharmaceutical and Biotech Companies Market Size and Forecast, 2012-2022
4.1.2.1. Revenue (US$ Mn) Comparison, By Region

4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region
4.1.3. Contract Research Organization Market Size and Forecast, 2012-2022
4.1.3.1. Revenue (US$ Mn) Comparison, By Region

4.1.3.2. Market Share Comparison, By Region
4.1.3.3. Y-o-Y growth Comparison, By Region
4.1.4. Regulatory Authorities Market Size and Forecast, 2012-2022
4.1.4.1. Revenue (US$ Mn) Comparison, By Region

4.1.4.2. Market Share Comparison, By Region
4.1.4.3. Y-o-Y growth Comparison, By Region
4.1.5. Other End Users Market Size and Forecast, 2012-2022

4.1.5.1. Revenue (US$ Mn) Comparison, By Region
4.1.5.2. Market Share Comparison, By Region
4.1.5.3. Y-o-Y growth Comparison, By Region

5. Global Biosimulation Market Analysis and Forecast By Application
5.1. Global Biosimulation Market Size and Forecast By Application, 2012-2022
5.1.1. Drug Development Market Size and Forecast, 2012-2022
5.1.1.1. Revenue (US$ Mn) Comparison, By Region

5.1.1.2. Market Share Comparison, By Region
5.1.1.3. Y-o-Y growth Comparison, By Region
5.1.2. Drug Discovery Market Size and Forecast, 2012-2022
5.1.2.1. Revenue (US$ Mn) Comparison, By Region

5.1.2.2. Market Share Comparison, By Region
5.1.2.3. Y-o-Y growth Comparison, By Region
5.1.3. Other Applications Market Size and Forecast, 2012-2022

5.1.3.1. Revenue (US$ Mn) Comparison, By Region
5.1.3.2. Market Share Comparison, By Region
5.1.3.3. Y-o-Y growth Comparison, By Region

Continued……

Buy Now@ https://www.persistencemarketresearch.com/checkout/3726

ABOUT US:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

CONTACT:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.